GeneMatrix announced on May 16th that it acquired a patent for 'Sequencing Method of Gene Target Site and Composition for Analysis'. The content of this patent is a method of generating a stepwise amplification product of a target gene using a gene restriction enzyme and a method of analyzing the base sequence of a target gene by measuring the mass of the generated amplification product.

We plan to apply this patent to the development of a method for sequencing human genomes and pathogen genes, and use them for molecular diagnostic testing and commercialization of medical diagnostic devices.